Global Ablation Catheters Market 2016-2020
About Ablation Catheters
Treatment for cardiac arrhythmias involves the use of endovascular catheter ablation procedures. This involves the use of ablation catheters that use various energy sources such as radiofrequency (RF) waves to destroy unhealthy heart tissues or faulty electrical pathways from the heart. The use of minimally invasive procedures has further helped improve catheter ablation techniques. Minimally invasive procedures help reduce blood loss, recovery duration, and hospital stay and offers improved medical outcomes.
Technavio’s analysts forecast the global ablation catheters market to grow at a CAGR of 12.58% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global ablation catheters market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of ablation catheters.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Ablation Catheters Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Ablation Catheters Market: Biosense Webster Inc. (a subsidiary of Johnson & Johnson), Boston Scientific Corp., Medtronic plc, and St. Jude Medical Inc.
Other Prominent Vendors in the market are: Advanced Cardiac Therapeutics, Angiodynamics, APT Medical, Atricure, Biotronik, CardioFocus, Covidien, DVx, Edwards Lifesciences, Estech, Hansen Medical, Imricor Medical Systems, Japan Lifeline, Lepu Medical, Melys AFSM, MicroPort, Osypka, PLC Medical Systems, Spectranetics, and Stereotaxis.
Commenting on the report, an analyst from Technavio’s team said: “Government and non-profit organizations are conducting various programs to create awareness about cardiac arrhythmia and associated treatment procedures. These organizations hold workshops to educate people on the efficient use of ablation catheters to improve the quality of life.”
According to the report, catheter ablation is a type of minimally invasive procedure that helps remove the heart tissues generating faulty electrical impulses. In 2014, in the US, 240,000 cardiac ablation procedures were performed. This rising preference for catheter ablation to treat arrhythmias and atrial fibrillation will increase the demand and use of ablation catheters worldwide.
Further, the report states that a lack of skilled electrophysiologists affects the market negatively.
Biosense Webster Inc. (a subsidiary of Johnson & Johnson), Boston Scientific Corp., Medtronic plc, St. Jude Medical Inc, Advanced Cardiac Therapeutics, Angiodynamics, APT Medical, Atricure, Biotronik, CardioFocus, Covidien, DVx, Edwards Lifesciences, Estech, Hansen Medical, Imricor Medical Systems, Japan Lifeline, Lepu Medical, Melys AFSM, MicroPort, Osypka, PLC Medical Systems, Spectranetics, Stereotaxis.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook